High-Dose Micafungin in Neonates and Young Infants with Invasive Candidiasis: Results of a Phase 2 Study

Limited data are available on the most appropriate dosing, efficacy, and safety of micafungin in neonates and young infants with invasive candidiasis (IC). This study evaluated plasma levels, efficacy, and safety of micafungin at a dose of 8 mg/kg daily for a mean of 13.3 days (±5.2 days) in 35 neon...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Antimicrob Agents Chemother
Päätekijät: Auriti, Cinzia, Goffredo, Bianca M., Ronchetti, Maria P., Piersigilli, Fiammetta, Cairoli, Sara, Bersani, Iliana, Dotta, Andrea, Bagolan, Pietro, Pai, Manjunath P.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Society for Microbiology 2021
Aiheet:
Clinical Therapeutics
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC8097467/
https://ncbi.nlm.nih.gov/pubmed/33558294
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02494-20
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia